QuidelOrtho QDEL
NASDAQ QDEL
$14.84 +1.04 (+7.54%)
As of: Aug 20, 2026 · 3:59 PM EDT

QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026)

QuidelOrtho (QDEL) posted Liabilities and Shareholders Equity of $5.6 billion for Q1 2026, down 2.44% sequentially from $5.8 billion in Q4 2025, and down 12.89% YoY from $6.5 billion in Q1 2025.

QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

QuidelOrtho has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $5.6 billion in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 12.89% year-over-year to $5.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 billion (down 11.08% YoY) and the FY2025 annual result came in at $5.8 billion, down 10.19% from the prior year.
  • Liabilities and Shareholders Equity retreated to $5.6 billion in Q1 2026 per QDEL's latest filing, from $5.8 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $8.9 billion in Q1 2023 and troughed at $2.4 billion in Q1 2022.
  • A 5-year average of $7.0 billion and a median of $6.7 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity jumped 264.38% in 2023, then fell 24.99% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $8.7 billion in 2022, then decreased by 1.07% to $8.6 billion in 2023, then fell by 24.99% to $6.4 billion in 2024, then dropped by 10.19% to $5.8 billion in 2025, then retreated by 2.44% to $5.6 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $5.6 billion, $5.8 billion, and $5.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 QuidelOrtho 1.01 Bn 885.73 Mn - 5.72 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 5.72 Bn
Mar 29, 2026 5.63 Bn
Dec 28, 2025 5.77 Bn
Sep 28, 2025 5.68 Bn
Jun 29, 2025 6.38 Bn
Mar 30, 2025 6.46 Bn
Dec 29, 2024 6.42 Bn
Sep 29, 2024 6.80 Bn
Jun 30, 2024 6.69 Bn
Mar 31, 2024 6.70 Bn
Dec 31, 2023 8.56 Bn
Oct 1, 2023 8.54 Bn
Jul 2, 2023 8.55 Bn
Apr 2, 2023 8.79 Bn
Jan 1, 2023 8.86 Bn
Oct 2, 2022 8.66 Bn
Jul 3, 2022 8.82 Bn
Jan 2, 2022 2.43 Bn